Startek to Review Takeover Bid; Bullish Stance on Ardelyx
- August 25th, 2023
- 504 views
Shares of Startek, Inc. (NYSE: SRT) surged in after-hours trading following the announcement of a special committee of independent directors to assess the non-binding proposal by CSP Management Limited, dated July 18, 2023, which suggests acquiring all the remaining shares of Startek at a rate of $3.80 in cash per share.
CSP Management currently holds around 56% stake in Startek. Notably, the proposal from CSP indicates that it has no intentions of selling its interests in Startek or considering any collaboration or sale of assets to other potential parties.
$SRT was trading at $3.16 in after-hours, up $0.15 (+4.98%).
In other news, Ardelyx, Inc. (Nasdaq: ARDX), a pharmaceutical company, received a boost in investor sentiment as Cantor Fitzgerald upgraded the company from Neutral to Overweight and raised the price target from $5 to $10.
Considering that $ARDX closed at $3.94 on Friday, this revised price target indicates a potential upside of $6.06 or approximately 153.81%, based on the financial services firm's assessment.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
September 04th, 2026Signing Day Is Not the End of Recruiting
September 04th, 2026Treasury, IRS Move to End Tax-Exempt Status for Discriminatory Practices in Private Schools
September 03rd, 2026FDA Approves First Drug to Treat Alexander Disease
September 03rd, 2026How Coaching Staffs Evaluate Athletes Across a Season
September 03rd, 2026
Member Login